Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Phathom, So the funding of the healthcare shares will be based on the closing date? So the higher the share price goes the less dilutive of shares . So say we are at $10 a share and we get $25 million we will only issue an additional 2.5 million shares?
38 million shares x$26 price target equals $988 million market cap when they merge. Market is worth $800 million and Tappimmune is worth 200 million approx. that is my targets at the merger Pete Hoang said marker is worth between $600 to $800 million . I used $800 million in my projections????my price target is $26
Cool I will let you know the dates later in the year. Why would anyone sell at these levels?
I vote for Vegas in May!! I go every year. I will let you know what week I will be there next year.
I will listen Burr. I think our CEO is a stud. I found that he might partner with China or Japan to test Asians with the marker solution . I don't have any idea how it gets approved in China or Japan but I found that interesting.
The Ceo Hoang said it on the red chip presentation in about the first five minutes of him speaking.
Bought more shares this morning. Why would anyone sell their shares at these prices since the valuation just for marker is between 600 to 800 million ??
Someone bought around 30k in shares in one trade. The word is spreading
Love the plan! Have about 38 million shares outstanding with a $125 million market cap based on current prices with $25 million in cash. So we will have funding 2020 when a lot of results are known. I am all in. If the price goes up before tbe merger than fewer than 38 million shares.
Thanks Phathom.
Phathom, what public release was the $25 million in? Thanks the big pharmacy are probrably not interested in the ovarian cancer results since it is an orphan drug status (not enough woman get it) as breast cancer with Dics.
Might as well have the sellers dump their Tpiv shares since there are us others who are parting with our stakes for the foreseeable future.
Agree with my friend Marv's first few sentences. Where we differ is that if Market s AML study is better than Kites drug and they got bought out for $11.9 billion . Then I can risk buying more shares now with a $100 million market cap. So I say buy and we will be at $10 before we hit $1 per share.
Burr, it ain't going to $1 per share like our smart friend projects! Lol one.billion is a start. Hoping for more thou.
Based on my name i added 2,800 shares this week and like my buddy burr I have 18k shares now. I am on the same wavelength as my Canadian friend. A market cap of $100 million is ridiculously low. I am just trying to figure out how much this entity is worth? I know it is well north of $100 million and thanks phantom for being smart ! Vegas is wonderful and I am having a great time here.
Phantom , please ask how much cash is on markers balance sheet and how many employees does marker have and what is their quarterly cash burn rate ? Thanks
Phantom , could you ask how many employees and how much cash marker has? Thanks what is markers. Quarterly cash burn?
My thoughts: I trust our CEO and like the minimal amount of new shares of $1.3 millions and getting rid of more warrants and I bought more shares this morning. My overall average cost per share is around $3.65 . I like the fact their studies are not toxic and the cost to manufacture will be low. Eventually big pharma will be after us once our studies are further along.
Well said Lloyd, I knew about the 1st investment firm but not the second. The risk reward ratio is in their favor with a market cap of only $30 million.
Listened to speech yesterday, thelong term survival of the 570 days to 700 days of the 10 women for 1st remission's ovarian cancer survival when normal progression is 313 days sounds quite promising to me. 3 of the 4 doing well taking Tpiv on second remission of ovarian cancer doing better than taking nurapimin (toxic treatment) and the 8 women still surviving with the triple negative taking Tpiv it is only a matter of time until this stock takes off. I am a believer that once our trials get to scale we are looking at approval.
How is Katryn Staton doing from a science perspective after receiving her treatment? Can he shed any light on her
Ask him, what type of feedback he has received from pharma companies and potential investors after his presentations at the conferences that he spoke at about the science results that he presented? What was the sizes of the audiences at the three events? How many attendees where in Switzerland ?
I won't be happy with a $1 billion buyout. I would rather remain independent .
As a Michigan alum, go Blue and Tpiv!! Very positive results from phase I . I would love that somehow we raise enough money to not get bought out. The market cap would get huge if we could remain solo and just do partnership.
The only genius to sell at these levels is Dakota! I think new financing will be over $5 per share. We shall see who is right. Time will tell.
Very little downside share price risk at these levels IMO
Why is this huge news? Results will be soon?
My take is this is really good news! Another signal that Tpiv200 will eventual prove that it will work and this is the hardest trial to pass in the degree of difficulty .
Hey genius, what is your price per share u paid for Tpiv?
Listen to his presentation. He didn't get into those specifics
CEO said progression free survival looks really long . Then said interesting long for 10 ovarian individuals.
CEO stated 3rd Round of DOD funding in his presentation and talked about long term progression free survival along with the biggest side affect to Tpiv200 was the redness around where the injection is. So the dod must think this vaccine works or the money wouldn't be forthcoming at this point.
The department of defense must believe the vaccine works!!! Why else would they give another grant of cash unless they believe that the vaccine will work for women.
Did you get kicked out of speech like i did? What happened?
Marv will provide the honorable mention for TPIV200 vaccine! Lol. He thinks the vaccine works now after that news video. Right Marv?
Believe CEO was giving info on phase Ii results that still aren't officially published since he referenced long term results.
Phantom, why do you think the 2 years results are still not out? Do you think this is a red flag? Thanks I thought the CEO hinted that the trial results were positive .
Sure is quite.. Even when we are up. I wonder why the 2 year results are still not published?
Thanks....I guess we need financing from others then when we need cash. I would prefer some sort of licensing of polystart to raise money .
Phathom, is that some warrant holders want to buy the underlying stock and this will generate cash for Tpiv for the warrants that are exercised? This would be good news .